Tradewinds Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $760K | Sell |
3,020
-480
| -14% | -$103K | 0.14% | 53 |
|
|
2026
Q1 | $761K | Sell |
3,500
-22
| -0.6% | -$4.88K | 0.15% | 48 |
|
|
2025
Q4 | $805K | Sell |
3,522
-138
| -4% | -$31.4K | 0.17% | 48 |
|
|
2025
Q3 | $847K | Sell |
3,660
-265
| -7% | -$54K | 0.19% | 51 |
|
|
2025
Q2 | $729K | Hold |
3,925
| – | – | 0.18% | 49 |
|
|
2025
Q1 | $822K | Sell |
3,925
-296
| -7% | -$57.5K | 0.22% | 44 |
|
|
2024
Q4 | $750K | Buy |
4,221
+3,771
| +838% | +$693K | 0.2% | 53 |
|
|
2024
Q3 | $88.9K | Hold |
450
| – | – | 0.02% | 141 |
|
|
2024
Q2 | $77.2K | Hold |
450
| – | – | 0.02% | 143 |
|
|
2024
Q1 | $81.9K | Sell |
450
-50
| -10% | -$8.62K | 0.02% | 130 |
|
|
2023
Q4 | $77.5K | Hold |
500
| – | – | 0.03% | 97 |
|
|
2023
Q3 | $74.5K | Sell |
500
-150
| -23% | -$22K | 0.03% | 94 |
|
|
2023
Q2 | $87.6K | Sell |
650
-5
| -0.8% | -$733 | 0.03% | 90 |
|
|
2023
Q1 | $104K | Buy |
655
+154
| +31% | +$23.5K | 0.03% | 71 |
|
|
2022
Q4 | $81K | Buy |
501
+160
| +47% | +$24.5K | 0.04% | 76 |
|
|
2022
Q3 | $46K | Buy |
341
+41
| +14% | +$5.88K | 0.02% | 114 |
|
|
2022
Q2 | $46K | Sell |
300
-1,378
| -82% | -$211K | 0.02% | 115 |
|
|
2022
Q1 | $272K | Hold |
1,678
| – | – | 0.04% | 97 |
|
|
2021
Q4 | $227K | Buy |
1,678
+200
| +14% | +$23.6K | 0.03% | 115 |
|
|
2021
Q3 | $159K | Hold |
1,478
| – | – | 0.03% | 128 |
|
|
2021
Q2 | $166K | Buy |
1,478
+300
| +25% | +$33.8K | 0.03% | 131 |
|
|
2021
Q1 | $127K | Hold |
1,178
| – | – | 0.03% | 136 |
|
|
2020
Q4 | $126K | Hold |
1,178
| – | – | 0.03% | 135 |
|
|
2020
Q3 | $103K | Buy |
1,178
+185
| +19% | +$17.4K | 0.02% | 132 |
|
|
2020
Q2 | $97K | Sell |
993
-191
| -16% | -$16.8K | 0.03% | 138 |
|
|
2020
Q1 | $90K | Sell |
1,184
-368
| -24% | -$31.3K | 0.03% | 134 |
|
|
2019
Q4 | $137K | Buy |
1,552
+70
| +5% | +$5.81K | 0.04% | 121 |
|
|
2019
Q3 | $112K | Sell |
1,482
-205
| -12% | -$14.1K | 0.04% | 114 |
|
|
2019
Q2 | $123K | Sell |
1,687
-213
| -11% | -$16.7K | 0.05% | 109 |
|
|
2019
Q1 | $153K | Sell |
1,900
-102
| -5% | -$8.34K | 0.06% | 119 |
|
|
2018
Q4 | $185K | Sell |
2,002
-684
| -25% | -$60.2K | 0.09% | 98 |
|
|
2018
Q3 | $254K | Buy |
2,686
+3
| +0.1% | +$284 | 0.1% | 90 |
|
|
2018
Q2 | $249K | Buy |
2,683
+184
| +7% | +$18K | 0.1% | 87 |
|
|
2018
Q1 | $237K | Buy |
2,499
+228
| +10% | +$25K | 0.11% | 91 |
|
|
2017
Q4 | $220K | Buy |
2,271
+1
| +0% | +$94 | 0.11% | 96 |
|
|
2017
Q3 | $202K | Buy |
2,270
+1
| +0% | +$76 | 0.1% | 97 |
|
|
2017
Q2 | $165K | Hold |
2,269
| – | – | 0.09% | 109 |
|
|
2017
Q1 | $148K | Buy |
2,269
+1,057
| +87% | +$66.5K | 0.09% | 111 |
|
|
2016
Q4 | $76K | Sell |
1,212
-102
| -8% | -$6.23K | 0.05% | 158 |
|
|
2016
Q3 | $83K | Buy |
1,314
+2
| +0.2% | +$129 | 0.06% | 151 |
|
|
2016
Q2 | $81K | Sell |
1,312
-56
| -4% | -$3.41K | 0.06% | 151 |
|
|
2016
Q1 | $78K | Buy |
1,368
+56
| +4% | +$3.12K | 0.05% | 172 |
|
|
2015
Q4 | $78K | Buy |
1,312
+200
| +18% | +$11.5K | 0.06% | 167 |
|
|
2015
Q3 | $61K | Hold |
1,112
| – | – | 0.05% | 188 |
|
|
2015
Q2 | $75K | Hold |
1,112
| – | – | 0.05% | 181 |
|
|
2015
Q1 | $65K | Hold |
1,112
| – | – | 0.05% | 185 |
|
|
2014
Q4 | $73K | Sell |
1,112
-133
| -11% | -$8.38K | 0.05% | 174 |
|
|
2014
Q3 | $72K | Hold |
1,245
| – | – | 0.05% | 174 |
|
|
2014
Q2 | $70K | Hold |
1,245
| – | – | 0.05% | 185 |
|
|
2014
Q1 | $64K | Hold |
1,245
| – | – | 0.05% | 195 |
|
|
2013
Q4 | $66K | Buy |
+1,245
| New | +$61.2K | 0.05% | 182 |
|
Other funds holding ABBV
Tradewinds Capital Management's ABBV Position: Q2 2026 in Review
Tradewinds Capital Management reduced its AbbVie (ABBV) stake by 14% in Q2 2026, selling an estimated $103K and leaving 3,020 shares worth $760K. The position accounts for 0.14% of the portfolio, ranked #53.
Tradewinds Capital Management first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. The position peaked at $847K in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Tradewinds Capital Management held 3,020 shares of AbbVie worth $760K as of Q2 2026.
- Tradewinds Capital Management sold 480 AbbVie shares in Q2 2026, an estimated $103K.
- AbbVie made up 0.14% of Tradewinds Capital Management's portfolio in Q2 2026, its #53 holding.
- Tradewinds Capital Management first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- Tradewinds Capital Management's AbbVie position peaked at $847K in Q3 2025.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.